ConductScience.org, home

Paper39735331

CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression.

Wang X and 5 others. Cytotechnology, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression. Papers, record 39735331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39735331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression.
PubMed
Journal
Cytotechnology
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-02-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XXiaohui
2Meng PPing
3Liu HHuili
4Tan JJinhua
5Liu YYu
6Li XXu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135637952CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression.Int J Biol Sci2022https://conductscience.org/library/papers/35637952PubMed
232247999Immunotherapy for pancreatic cancer: A 2020 update.Cancer Treat Rev2020https://conductscience.org/library/papers/32247999PubMed
335172803Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker.BMC Med Genomics2022https://conductscience.org/library/papers/35172803PubMed
429678579CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29678579PubMed
536096734KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion.Biol Proced Online2022https://conductscience.org/library/papers/36096734PubMed
634216688Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis.Cancer Lett2021https://conductscience.org/library/papers/34216688PubMed
733116867CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.Cancer Manag Res2020https://conductscience.org/library/papers/33116867PubMed
836173644A comprehensive review of pancreatic cancer and its therapeutic challenges.Aging (Albany NY)2022https://conductscience.org/library/papers/36173644PubMed
936830695Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.Biomolecules2023https://conductscience.org/library/papers/36830695PubMed
1034785774Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.Oncogene2022https://conductscience.org/library/papers/34785774PubMed
1138125441FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response.Heliyon2023https://conductscience.org/library/papers/38125441PubMed
1234002083Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/34002083PubMed
1337674204CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity.J Transl Med2023https://conductscience.org/library/papers/37674204PubMed
1436798768Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer.Heliyon2023https://conductscience.org/library/papers/36798768PubMed
1523313480Heterochromatin protein 1γ overexpression in P19 embryonal carcinoma cells elicits spontaneous differentiation into the three germ layers.Biochem Biophys Res Commun2013https://conductscience.org/library/papers/23313480PubMed
1636923407Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer.Front Immunol2023https://conductscience.org/library/papers/36923407PubMed
1735280819An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma.Front Oncol2022https://conductscience.org/library/papers/35280819PubMed
1837489138Advances and Prospects in the Treatment of Pancreatic Cancer.Int J Nanomedicine2023https://conductscience.org/library/papers/37489138PubMed
1934796785PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis.Channels (Austin)2021https://conductscience.org/library/papers/34796785PubMed
2036842769Liquid biopsy in pancreatic cancer - Current perspective and future outlook.Biochim Biophys Acta Rev Cancer2023https://conductscience.org/library/papers/36842769PubMed

See all 30 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CBX311335PubTator's text mininghttps://conductscience.org/library/genes/11335NCBI Gene
KIF20A10112PubTator's text mininghttps://conductscience.org/library/genes/10112NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39735331

GET https://conductscience.org/api/papers/v1/39735331/references?page=2